To our knowledge, this is the first demonstration that CHI3L1 directly fuels astrocyte activation in an autocrine loop, reframing NMO as an astrocyte-intrinsic amplifier of CNS inflammation and demyelination and opening tractable astrocyte-targeted therapeutic avenues. This evidence concerns the gene CHI3L1 and neuromyelitis optica.